Breathing apparatus detection and purging

US9550040B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9550040-B2
Application numberUS-201514827523-A
CountryUS
Kind codeB2
Filing dateAug 17, 2015
Priority dateApr 5, 2012
Publication dateJan 24, 2017
Grant dateJan 24, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described are methods for safer nitric oxide delivery, as well as apparatuses for performing these methods. The methods may include detecting the presence or absence of a nasal cannula, and stopping the delivery of nitric oxide or providing an alert if the cannula is disconnected. The methods may also include purging the nasal cannula if it is reconnected after a disconnection or if it is replaced by a new cannula. Other methods pertain to automatic purging of the delivery conduit if the elapsed time between successive deliveries of therapeutic gas exceeds a predetermined period of time.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of administering therapeutic gas containing nitric oxide, the method comprising: sensing inspiration of a patient; during patient inspiration, delivering a pulse of the therapeutic gas containing nitric oxide through one or more valves along a conduit and subsequently through a nasal cannula having one or more nares to the patient; measuring an elapsed time since the last delivery of the therapeutic gas to the patient; determining that the elapsed time exceeds a predetermined period of time; and purging the nasal cannula with a purge volume greater than a volume of the one or more nares and less than a total internal volume of the nasal cannula. 2. The method of claim 1 , wherein purging the nasal cannula comprises opening one of the one or more valves to deliver a pulse of the therapeutic gas during patient expiration. 3. The method of claim 1 , wherein one or more patient breaths are detected between successive deliveries of the therapeutic gas. 4. The method of claim 1 , wherein the elapsed time is reset when the nasal cannula is purged. 5. The method of claim 1 , wherein the predetermined period of time is in a range from 5 seconds to 15 seconds. 6. The method of claim 1 , wherein the predetermined period of time is in a range from 1 to 10 breaths. 7. The method of claim 1 , wherein the predetermined period of time is in a range from 2 to 20 seconds. 8. The method of claim 1 , wherein the purge volume is less than or equal to 1 mL. 9. The method of claim 1 , wherein the purge volume is less than or equal to 0.5 mL. 10. A method of administering therapeutic gas containing nitric oxide, the method comprising: delivering a pulse of the therapeutic gas containing nitric oxide to a patient via a nasal cannula having one or more nares; determining that an elapsed time since the last delivery of the therapeutic gas exceeds a predetermined period of time; and purging the nasal cannula with a purge volume greater than a volume of the one or more nares and less than a total internal volume of the nasal cannula. 11. The method of claim 10 , wherein purging the nasal cannula comprises opening one or more valves to deliver a pulse of the therapeutic gas during patient expiration. 12. The method of claim 10 , wherein one or more patient breaths are detected between successive deliveries of the therapeutic gas. 13. The method of claim 10 , wherein the elapsed time is reset when the nasal cannula is purged. 14. The method of claim 10 , wherein the predetermined period of time is in a range from 2 to 20 seconds. 15. The method of claim 10 , wherein the predetermined period of time is in a range from 5 seconds to 15 seconds. 16. The method of claim 10 , wherein the predetermined period of time is in a range from 1 to 10 breaths. 17. The method of claim 10 , wherein the purge volume is less than or equal to 1 mL. 18. The method of claim 10 , wherein the purge volume is less than or equal to 0.5 mL. 19. A nitric oxide delivery apparatus comprising: a source of therapeutic gas containing nitric oxide; a conduit in fluid communication with the source of the therapeutic gas; one or more valves disposed along the conduit that regulate a flow of the therapeutic gas through the conduit; a nasal cannula comprising one or more nares in fluid communication with the conduit that provides the therapeutic gas to a patient; a sensor that detects inspiration and/or expiration of the patient; a timer; and a control system in communication with the timer and the one or more valves that initiates purging of the nasal cannula when an elapsed time since the last delivery of the therapeutic gas exceeds a predetermined period of time, wherein the nasal cannula is purged with a purge volume greater than a volume of the one or more nares and less than a total internal volume of the nasal cannula. 20. The nitric oxide delivery apparatus of claim 19 , wherein the purge volume is less than or equal to 1 mL.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9550040B2 cover?
Described are methods for safer nitric oxide delivery, as well as apparatuses for performing these methods. The methods may include detecting the presence or absence of a nasal cannula, and stopping the delivery of nitric oxide or providing an alert if the cannula is disconnected. The methods may also include purging the nasal cannula if it is reconnected after a disconnection or if it is repla…
Who is the assignee on this patent?
Mallinckrodt Hospital Products Ip Ltd
What technology area does this patent fall under?
Primary CPC classification A61M16/202. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).